Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 22786716)


Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome.

Kuppermann M, Wang G, Wong S, Blanco A, Conrad P, Nakagawa S, Terdiman J, Ladabaum U.

Cancer. 2013 Jan 1;119(1):215-25. doi: 10.1002/cncr.27634. Epub 2012 Jul 11.


Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.


Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.

Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U.

Am J Manag Care. 2012 May 1;18(5):e179-85.


Comparative effectiveness of screening strategies for Lynch syndrome.

Barzi A, Sadeghi S, Kattan MW, Meropol NJ.

J Natl Cancer Inst. 2015 Mar 20;107(4). pii: djv005. doi: 10.1093/jnci/djv005. Print 2015 Apr.


Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Dinh TA, Rosner BI, Atwood JC, Boland CR, Syngal S, Vasen HF, Gruber SB, Burt RW.

Cancer Prev Res (Phila). 2011 Jan;4(1):9-22. doi: 10.1158/1940-6207.CAPR-10-0262. Epub 2010 Nov 18.


The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Mvundura M, Grosse SD, Hampel H, Palomaki GE.

Genet Med. 2010 Feb;12(2):93-104. doi: 10.1097/GIM.0b013e3181cd666c.


Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.

Dewanwala A, Chittenden A, Rosenblatt M, Mercado R, Garber JE, Syngal S, Stoffel EM.

Fam Cancer. 2011 Sep;10(3):549-56. doi: 10.1007/s10689-011-9448-8.


Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2009 Jan;11(1):35-41. doi: 10.1097/GIM.0b013e31818fa2ff.


Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.

Maradiegue A, Jasperson K, Edwards QT, Lowstuter K, Weitzel J.

J Am Acad Nurse Pract. 2008 Feb;20(2):76-84. doi: 10.1111/j.1745-7599.2007.00282.x. Review.


Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry.

Sturgeon D, McCutcheon T, Geiger TM, Muldoon RL, Herline AJ, Wise PE.

Dis Colon Rectum. 2013 Mar;56(3):308-14. doi: 10.1097/DCR.0b013e31827edfff.


Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.

Sharaf RN, Myer P, Stave CD, Diamond LC, Ladabaum U.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1093-100. doi: 10.1016/j.cgh.2013.04.044. Epub 2013 May 10. Review.


Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification?

Byfield SA, Syngal S.

Am J Gastroenterol. 2008 Nov;103(11):2837-40. doi: 10.1111/j.1572-0241.2008.02091.x.


Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A.

N Engl J Med. 2005 May 5;352(18):1851-60.


Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.

Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA; CERGEN study team.

Genet Med. 2013 Dec;15(12):933-40. doi: 10.1038/gim.2013.43. Epub 2013 May 2.


Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.

Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, Terdiman J, Chung DC, Syngal S.

Clin Gastroenterol Hepatol. 2008 Mar;6(3):333-8. doi: 10.1016/j.cgh.2007.12.014. Epub 2008 Feb 7.


Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges.

Marquez E, Geng Z, Pass S, Summerour P, Robinson L, Sarode V, Gupta S.

Genet Med. 2013 Dec;15(12):925-32. doi: 10.1038/gim.2013.45. Epub 2013 Apr 18.


ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis).

Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A; Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee.

Genet Med. 2014 Jan;16(1):101-16. doi: 10.1038/gim.2013.166. Epub 2013 Dec 5.


BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.

Capper D, Voigt A, Bozukova G, Ahadova A, Kickingereder P, von Deimling A, von Knebel Doeberitz M, Kloor M.

Int J Cancer. 2013 Oct 1;133(7):1624-30. doi: 10.1002/ijc.28183. Epub 2013 Apr 25.


Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.

Resnick K, Straughn JM Jr, Backes F, Hampel H, Matthews KS, Cohn DE.

Obstet Gynecol. 2009 Sep;114(3):530-6. doi: 10.1097/AOG.0b013e3181b11ecc.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk